Here, we have a chat with Billy Amzal, PhD, X-Eng, MSc, MPA, who has been appointed as Certara’s senior vice president, decision and real-world data analytics.
Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter.
In this online opinion piece, Mark Davison, head of operations in the EU for rfxcel, outlines everything marketing authorisation holders (MAHs) need to know and what is needed for a seamless serialisation process
Swedish based pharmaceutical development company, Kancera, has announced that unique blockers (antagonists) of the Fractalkine system have been patented, laying the foundations for the development of additional drug candidates.
According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market.
The US Food and Drug Administration (FDA) has issued warnings to two Chinese drug manufacturers for violations of good manufacturing practice (GMP), according to a post from the Regulatory Affairs Professionals Society (RAPS).
In this online exclusive, Paul Brooks, executive director, Regulatory Affairs Professionals Society (RAPS), looks at the impact Brexit may have on the healthcare product regulatory space and how clarity is urgently needed.
After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain
Now we have just passed the six-month marker (1 July) until the European Medicines Agency (EMA) moves from its current location in London to Amsterdam, as a result of Brexit, we gauge industry response to this change…
In this latest instalment of ‘Meet the maker’, we sit down with Peter Neve, chief marketing officer at ACG — a company that offers integrated manufacturing solutions for the pharmaceutical industry.
